Grifols GRFS
NASDAQ GRFS
$8.00 +0.01 (+0.13%)
At close: Aug 21, 2026 · 4:00 PM EDT

Grifols (GRFS) Other Non Operating Income (2009 - 2018)

Grifols' (GRFS) quarterly Other Non Operating Income came in at -$10.7 million in Q2 2018, down 169.64% YoY from $15.4 million in Q2 2017, and down 169.64% on a QoQ basis from $15.4 million in Q2 2017.

Grifols (GRFS) Other Non Operating Income (2009 - 2018) Analysis & Trends

Grifols (GRFS) has 10 years of Other Non Operating Income data on file, last reported at -$10.7 million in Q2 2018.

  • Quarterly Other Non Operating Income fell 169.64% year-over-year to -$10.7 million in Q2 2018, while the trailing twelve-month figure through Jun 2018 was $12.7 million (down 58.09% YoY) and the FY2025 annual result came in at -$64.0 million, changed 0.15% from the prior year.
  • Other Non Operating Income retreated to -$10.7 million in Q2 2018, from $15.4 million in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $23.1 million in Q4 2014 to a low of -$31.5 million in Q1 2014.
  • A 5-year average of -$4.8 million and a median of -$953337.4 in 2016 frame the typical range for Other Non Operating Income.
  • The widest YoY moves for Other Non Operating Income: up 2774.93% in 2014, down 531.08% in 2014.
  • Tracing GRFS's Other Non Operating Income over 5 years: stood at $23.1 million in 2014, then plunged by 157.64% to -$13.3 million in 2015, then soared by 152.42% to $7.0 million in 2016, then soared by 120.93% to $15.4 million in 2017, then sank by 169.64% to -$10.7 million in 2018.
  • The last three Other Non Operating Income figures came in at -$10.7 million (Q2 2018), $15.4 million (Q2 2017), and $7.0 million (Q4 2016), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn
10 Grifols 5.45 Bn 4.45 Bn -

Historic Data

Download Data
DateValue
Jun 30, 2018 -10.73 Mn
Jun 30, 2017 15.41 Mn
Dec 31, 2016 6.98 Mn
Sep 30, 2016 1.06 Mn
Jun 30, 2016 6.90 Mn
Mar 31, 2016 -2.97 Mn
Dec 31, 2015 -13.31 Mn
Sep 30, 2015 4.22 Mn
Jun 30, 2015 2.15 Mn
Mar 31, 2015 -12.85 Mn
Dec 31, 2014 23.09 Mn
Sep 30, 2014 -25.62 Mn
Jun 30, 2014 -29.84 Mn
Mar 31, 2014 -31.53 Mn
Dec 31, 2013 803,042.84
Sep 30, 2013 5.94 Mn
Jun 30, 2013 -35.64 Mn
Mar 31, 2013 -41.39 Mn
Dec 31, 2012 1.35 Mn
Sep 30, 2012 -43.52 Mn